CD19 and systemic lupus erythematosus: Anti-CD19 CAR-T cells have been studied in murine lupus, in which they resulted in a reduction in serum autoantibodies and amelioration of kidney pathology19,20; also, the results of anti-CD19 CAR-T therapy in SLE patients are encouraging21,22.